Abstract

Pten is one of the most frequently mutated tumour suppressor gene in cancer. PTEN is generally altered in invasive cancers such as glioblastomas, but its function in collective cell migration and invasion is not fully characterised. Herein, we report that the loss of PTEN increases cell speed during collective migration of non-tumourous cells both in vitro and in vivo. We further show that loss of PTEN promotes LKB1-dependent phosphorylation and activation of the major metabolic regulator AMPK. In turn AMPK increases VASP phosphorylation, reduces VASP localisation at cell-cell junctions and decreases the interjunctional transverse actin arcs at the leading front, provoking a weakening of cell-cell contacts and increasing migration speed. Targeting AMPK activity not only slows down PTEN-depleted cells, it also limits PTEN-null glioblastoma cell invasion, opening new opportunities to treat glioblastoma lethal invasiveness.

Pten is a tumour suppressor gene that is associated with highly invasive cancers such as glioblastoma. Here the authors show that PTEN loss results in increased migratory behaviour, which can be countered by targeting AMPK activity.

Details

Title
PTEN inhibits AMPK to control collective migration
Author
Peglion, Florent 1 ; Capuana, Lavinia 2   VIAFID ORCID Logo  ; Perfettini, Isabelle 1 ; Boucontet, Laurent 3   VIAFID ORCID Logo  ; Braithwaite, Ben 1 ; Colucci-Guyon, Emma 3 ; Quissac, Emie 4 ; Forsberg-Nilsson, Karin 5   VIAFID ORCID Logo  ; Llense, Flora 6 ; Etienne-Manneville, Sandrine 1   VIAFID ORCID Logo 

 Institut Pasteur, CNRS UMR3691, Université Paris Cité, Équipe Labellisée Ligue Contre le Cancer, Cell Polarity, Migration and Cancer Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535) 
 Institut Pasteur, CNRS UMR3691, Université Paris Cité, Équipe Labellisée Ligue Contre le Cancer, Cell Polarity, Migration and Cancer Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535); Sorbonne Université, Collège doctoral, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657) 
 Institut Pasteur, CNRS UMR3738, Macrophages and Development of Immunity Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535) 
 Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC University Paris 04 UMR S1127, Institut du Cerveau, ICM, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058) 
 Uppsala University, Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
 Institut Pasteur, CNRS UMR3691, Université Paris Cité, Équipe Labellisée Ligue Contre le Cancer, Cell Polarity, Migration and Cancer Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535); Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR7622, Paris, France (GRID:grid.503253.2) (ISNI:0000 0004 0520 7190) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2700915904
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.